FR2818551B1 - USE OF CHELATORS FOR THE TREATMENT OF PRION DISEASES - Google Patents

USE OF CHELATORS FOR THE TREATMENT OF PRION DISEASES

Info

Publication number
FR2818551B1
FR2818551B1 FR0015571A FR0015571A FR2818551B1 FR 2818551 B1 FR2818551 B1 FR 2818551B1 FR 0015571 A FR0015571 A FR 0015571A FR 0015571 A FR0015571 A FR 0015571A FR 2818551 B1 FR2818551 B1 FR 2818551B1
Authority
FR
France
Prior art keywords
chelators
treatment
prion diseases
prion
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0015571A
Other languages
French (fr)
Other versions
FR2818551A1 (en
Inventor
Claude Marc Pierre Hannoun
Michel Xilinas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0015571A priority Critical patent/FR2818551B1/en
Priority to AU2002216305A priority patent/AU2002216305A1/en
Priority to PCT/IB2001/002572 priority patent/WO2002051415A2/en
Publication of FR2818551A1 publication Critical patent/FR2818551A1/en
Application granted granted Critical
Publication of FR2818551B1 publication Critical patent/FR2818551B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
FR0015571A 2000-12-22 2000-12-22 USE OF CHELATORS FOR THE TREATMENT OF PRION DISEASES Expired - Fee Related FR2818551B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0015571A FR2818551B1 (en) 2000-12-22 2000-12-22 USE OF CHELATORS FOR THE TREATMENT OF PRION DISEASES
AU2002216305A AU2002216305A1 (en) 2000-12-22 2001-12-17 Use of sequestrants for treating prion diseases
PCT/IB2001/002572 WO2002051415A2 (en) 2000-12-22 2001-12-17 Use of sequestrants for treating prion diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0015571A FR2818551B1 (en) 2000-12-22 2000-12-22 USE OF CHELATORS FOR THE TREATMENT OF PRION DISEASES

Publications (2)

Publication Number Publication Date
FR2818551A1 FR2818551A1 (en) 2002-06-28
FR2818551B1 true FR2818551B1 (en) 2007-06-01

Family

ID=8857123

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0015571A Expired - Fee Related FR2818551B1 (en) 2000-12-22 2000-12-22 USE OF CHELATORS FOR THE TREATMENT OF PRION DISEASES

Country Status (3)

Country Link
AU (1) AU2002216305A1 (en)
FR (1) FR2818551B1 (en)
WO (1) WO2002051415A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1791408A (en) * 2003-04-03 2006-06-21 普拉纳生物技术有限公司 Treatment of neurological conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT959888E (en) * 1996-08-13 2002-02-28 Gerolymatos P N Sa Use of the chelating agent CLIOQUINOL FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
IL134263A (en) * 1997-08-21 2006-04-10 Gerolymatos P N Sa Pharmaceutical compositions containing phanquinone for the treatment of alzheimer's disease
US5994323A (en) * 1997-12-31 1999-11-30 P.N. Gerolymatos S.A. Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof
US6323218B1 (en) * 1998-03-11 2001-11-27 The General Hospital Corporation Agents for use in the treatment of Alzheimer's disease

Also Published As

Publication number Publication date
AU2002216305A1 (en) 2002-07-08
WO2002051415B1 (en) 2003-05-30
WO2002051415A3 (en) 2003-05-01
WO2002051415A2 (en) 2002-07-04
FR2818551A1 (en) 2002-06-28

Similar Documents

Publication Publication Date Title
MA26992A1 (en) PHENETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
MA26951A1 (en) PYRAZOLE DERIVATIVES FOR THE TREATMENT OF VIRAL DISEASES
MA27027A1 (en) PDE4 INHIBITOR AND ASSOCIATED ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE AIRWAY DISEASES
PL362711A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
DE60124576D1 (en) COMPOUNDS USE FOR THE TREATMENT OF INFLAMMATORY DISEASES
NO20026008D0 (en) Procedure for the treatment of cardiovascular diseases
PT986308E (en) TREATMENT OF MEAT BY DISCHARGE OF CONDENSER
DK1458399T3 (en) Pregnancy steroids for use in the treatment of CNS diseases
NO20023740D0 (en) Ocular hypotensive lipids
DE60134267D1 (en) PROPHYLACTIC / THERAPEUTIC AGENTS FOR INFLAMMATORY RESPIRATORY DISEASES
FR2818551B1 (en) USE OF CHELATORS FOR THE TREATMENT OF PRION DISEASES
IL141950A0 (en) Diagnosis of prion diseases
PL373490A1 (en) Use of beta-adrenoceptor agonists for the treatment of neurodegenerative diseases
MA25852A1 (en) METHOD FOR THE TREATMENT OF INFLAMMATION.
FR2800614B1 (en) COMPOSITION FOR THE TREATMENT OF RESPIRATORY INFECTIONS
MA26908A1 (en) S-METHYL-DIHYDRO-ZIPRASIDONE FOR THE TREATMENT OF PSYCHIATRIC AND EYE DISORDERS
DE60005685D1 (en) OXAZINOCARBAZOLE FOR THE TREATMENT OF CNS DISEASES
FR2749151B1 (en) DISPOSABLE PAD BOX FOR FOOTWEAR CLEANING
NO20032206L (en) Combination therapy for estrogen-dependent disorders
EE200300505A (en) Use of an aromatase inhibitor in the manufacture of a medicament for the treatment of infertility
FR2806293B1 (en) SCLERAL IMPLANTS FOR THE TREATMENT OF RETINE DISCOLUTION
FR2782007B1 (en) USE OF CALIX (N) ARENES FOR THE TREATMENT OF FIBROTIC DISEASES
MA25753A1 (en) THIAZOL IDINEDIONE SALT FOR THE TREATMENT OF DIABETES MELLIUS
FR2824727B1 (en) ORTHESIS OF THE INCH FOR THE TREATMENT OF METACARPO-PHALANGIAN SPRAYS
EP1252895A4 (en) Remedies for ophthalmic diseases

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20110831